New classes of drugs like Wegovy (a GLP-1 agonist similar to Ozempic) and Zepbound could certainly help the millions of obese Americans and people around the globe struggling to shed weight.

A shortage of weight-loss drugs such as the newly released Ozempic rival Zepbound, is forcing desperate customers to drive as much as five hours to find a pharmacy that has the pricey meds in stock.

while Zepbound received FDA approval for weight loss in November 2023. The table below introduces six stocks and one ETF that stand to benefit from Ozempic's popularity. The table is followed by a ...

A pharmacist holds a box of Novo Nordisk A/S Ozempic brand semaglutide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023 - Image: Bloomberg / Contributor (Getty Images ...